INSIGHTS ON PHARMACEUTICAL INSPECTION

• Managing Risk In The Most Complex Combination Device Format

  Autoinjectors add mechanical forces and interactions that change how container closure integrity must be evaluated. Learn why device complexity creates new risks and how testing strategies must adapt.

• Material Transfer Into A Cleanroom: How To Reduce Contamination Risk At Every Step

  Evaluate packaging integrity and master wiping techniques to prevent cleanroom contamination. Focus on surface coverage and controlled transfer paths to ensure consistent product safety and quality.

• 6 Things To Consider During Visual Inspection Operations

  Even with automation, manual visual inspection remains vital in sterile drug manufacturing. Discover six advanced considerations for refining your operations, ensuring compliance, and minimizing costs.

• M6 Tablet Metal Detector For Pharmaceutical And Nutraceutical Production

  Ensure the safety and quality of your tablets and capsules with a metal detector designed for stability and high sensitivity in pharmaceutical and nutraceutical production.

• Supporting GLP-1 And Peptides With Integrated Solutions

  9/30/2025

  Accelerate GLP-1 and peptide therapy development with integrated drug containment, delivery, machinery, and analytics for reliable combination product performance.

• HVLD Technology Pre-Filled Syringe Inspection

  1/5/2026

  Advanced HVLD technology delivers non-invasive, deterministic inspection for pre-filled syringes. Learn how this method improves reliability and patient safety compared to traditional approaches.

• Test Kit Management: The Hidden Weak Point In Your Visual Inspection Program

  9/17/2025

  A proper test kit management program is no longer a “nice-to-have”—it’s a compliance necessity. Without a structured system, you risk inspector drift, failed audits, and errors in batch release.

• Part II: Defining The Dye Ingress Operating Window

  2/12/2026

  Learn about the viscosity-driven limits of dye ingress testing, translating qualitative constraints into a quantitative feasibility boundary shaped by defect size, pressure behavior, and plunger mechanics.

• Automated PUPSIT For Drug Product Applications

  1/13/2026

  Automated filtration systems streamline PUPSIT, leak testing, and integrity checks to ensure sterile drug product processing. Learn how these methods improve contamination control and compliance.